ZEPP
Get informed when a big investor buys or sells
+ FollowOvervalued by 266.8% based on the discounted cash flow analysis.
| Market cap | $3.17 Million |
|---|---|
| Enterprise Value | $951.89 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-283.04 |
| Beta | 1.81 |
| Outstanding Shares | 989,673 |
| P/E Ratio | -0.08 |
|---|---|
| PEG | -0.01 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | 0.49 |
| Enterprise Value to EBIT | -3.96 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 1.75 |
| Debt to Equity | 1.33 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0436▼ 11.56% |
|---|---|
| Total Calls | 34,400▼ 41.10% |
| Total Puts | 35,900▼ 46.97% |
Holdings and activity of institutional investors.
| Ownership % | 228.16%▼ 120.54% |
|---|---|
| Total Invested | $11.76M▼ 71.54% |
| Investors Holding | 30▼ 4.00% |
No data
Zepp Health's mission is to connect health with technology. Since its inception in 2013, the company has developed a platform of proprietary technology including AI chips, biometric sensors, and data algorithms, which drive a broadening ...